May 12, 2026 05:03PM
Apr 16, 2026 08:50AM
Apr 13, 2026 07:39AM
Mar 31, 2026 04:46PM
Mar 31, 2026 07:35AM
Feb 24, 2026 04:07PM
Feb 23, 2026 08:40AM Palisade Bio presents PALI-2108 data showing clinical response in UC patients
Jan 9, 2026 01:08AM
Jan 7, 2026 08:17AM
Dec 30, 2025 08:35AM
Dec 29, 2025 04:07PM
Dec 29, 2025 03:39AM
Dec 2, 2025 08:45AM
Oct 13, 2025 08:46AM Palisade Bio receives Canadian patent for PALI-2108 drug composition
Sep 29, 2025 06:47AM
Sep 26, 2025 04:05PM
Aug 15, 2025 04:09PM
Jul 22, 2025 08:40AM
Jul 9, 2025 08:45AM
May 27, 2025 08:33AM
May 6, 2025 08:32AM Palisade Bio (PALI) Presents Positive Preclinical Data Highlighting Potential of PALI-2108
Apr 9, 2025 08:31AM
Mar 12, 2025 08:32AM
Feb 20, 2025 08:46AM
Feb 10, 2025 08:45AM
Jan 16, 2025 08:03AM
Dec 17, 2024 08:34AM
Dec 12, 2024 12:08PM Palisade Bio (PALI) Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules
Nov 12, 2024 04:48PM
Nov 7, 2024 08:31AM
Oct 31, 2024 08:33AM
Oct 30, 2024 06:10AM
Oct 10, 2024 08:32AM
Sep 25, 2024 08:01AM
Sep 5, 2024 08:01AM Palisade Bio Inc. (PALI) Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient Stratification
Aug 13, 2024 10:35AM
Aug 8, 2024 08:00AM
Jul 29, 2024 09:08AM
Jul 19, 2024 08:32AM
Jul 11, 2024 08:05AM
Jun 21, 2024 08:15AM
Jun 11, 2024 08:34AM Palisade Bio (PALI) Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108

404,881 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All